[Utility of the for patient participation in the identification of chemotherapy-induced toxicity according to the CTCAE classification].

Objective: Since 2003, the National Cancer Institute (NCI) of the United States of America has been one of the world leaders in classifying adverse effects (AEs). Currently, smartphones allow, among many other things, the monitoring of these AEs of chemotherapy from home to improve the safety and quality of life of patients. The aim was to perform a descriptive comparative analysis of the AEs content of the and the latest version of the CTCAE (Common Terminology Criteria for Adverse Events).

[Descriptive analysis of the mobile applications for registering and monitoring the adverse effects of antineoplastic drugs according to the evaluation methodology of and the Tic Salut Social Foundation].

Objective: The daily use of mobile healthcare applications is already a reality around the world. Their supply and demand forecasts continue to increase exponentially due to the multiple facilities and improvements that they can offer to health management and patient-centered care, especially for the chronically ill. However, this exponential growth in the offer confuses when choosing the best mobile application to use due to the lack of scientific evidence on whether they meet the safety criteria for patients and professionals.